Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 9143730)

1.

Pharmacoeconomics: state of the art in 1997.

Schulman KA, Linas BP.

Annu Rev Public Health. 1997;18:529-48. Review.

PMID:
9143730
2.

Update on pharmacoeconomics in transplantation.

Cavanaugh TM, Martin JE.

Prog Transplant. 2007 Jun;17(2):103-19; quiz 120. Review.

PMID:
17624133
3.

Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development.

Bodrogi J, Kaló Z.

Br J Pharmacol. 2010 Apr;159(7):1367-73. doi: 10.1111/j.1476-5381.2009.00550.x. Epub 2010 Feb 2. Review.

4.

Pharmacoeconomics of dementia.

Whitehouse PJ.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 5:S22-32; discussion S32-3.

PMID:
9348424
5.

Interest of modelling in rheumatoid arthritis.

Beresniak A, Dupont DM, Becker JC, Merkesdal S.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S96-101. Epub 2012 Oct 18. Review.

PMID:
23078913
6.

[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].

Führlinger S.

Wien Med Wochenschr. 2006 Dec;156(23-24):612-8. German.

PMID:
17211765
7.

Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.

Reeder CE.

Am J Health Syst Pharm. 1995 Oct 1;52(19 Suppl 4):S5-8. Review.

PMID:
8846244
8.

[Pharmacoeconomics].

Shiragami M.

Yakugaku Zasshi. 2003 Mar;123(3):133-42. Review. Japanese.

9.

The power of pharmacoeconomics.

[No authors listed]

Healthc Exec. 2000 Jan-Feb;15(1):44-5. No abstract available.

PMID:
11067028
10.

Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?

Brinsmead R, Hill S.

J Clin Pharm Ther. 2003 Aug;28(4):339-46.

PMID:
12911687
11.

Pharmacoeconomics.

Ahuja J, Gupta M, Gupta AK, Kohli K.

Natl Med J India. 2004 Mar-Apr;17(2):80-3. Review.

PMID:
15141600
12.

The rationale of pharmacoeconomic analysis in rheumatologic indications.

Turchetti G, Scalone L, Della Casa Alberighi O, Mosca M, Montella S, Cortesi PA, Mantovani LG.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S64-71. Epub 2012 Oct 18.

PMID:
23072796
13.

[Pharmacoeconomics: basic concepts and applications to clinical anesthesia].

Ortiz-Gómez R, Fornet-Ruiz I, Palacio-Abizanda FJ.

Rev Esp Anestesiol Reanim. 2011 May;58(5):295-303. Spanish.

PMID:
21688508
14.

The state of health economic research in South Africa: a systematic review.

Gavaza P, Rascati KL, Oladapo AO, Khoza S.

Pharmacoeconomics. 2012 Oct 1;30(10):925-40. doi: 10.2165/11589450-000000000-00000. Review.

PMID:
22809450
15.

[Pharmacoeconomics in contemporary medicine].

Czech M.

Pol Merkur Lekarski. 2004 May;16 Suppl 1:16-9. Review. Polish.

PMID:
15524007
16.

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR; ISPOR Task Force on Good Research Practices--Modeling Studies.

Value Health. 2003 Jan-Feb;6(1):9-17.

PMID:
12535234
17.
18.

Pharmacoeconomics and formulary decision making.

Sanchez LA.

Pharmacoeconomics. 1996;9 Suppl 1:16-25.

PMID:
10160112
19.

Evaluation and review of pharmacoeconomic models.

Hay JW.

Expert Opin Pharmacother. 2004 Sep;5(9):1867-80. Review.

PMID:
15330725
20.

Presenting economic information for decision making.

Pelc A.

Pharmacoeconomics. 1994 Oct;6(4):346-51.

PMID:
10147471
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk